Influence of estradiol analogue on cell growth, morphology and death in esophageal carcinoma cells

Biocell

Volumn 34, Issue 3, 2010, Pages 113-120

  Mqoco, Thandi ^a   Marais, Sumari ^a   Joubert, Annie ^a  

^a UNIVERSITY OF PRETORIA   (South Africa)

Author keywords

Apoptosis; Autophagy; Cancer

Indexed keywords

2 METHOXYESTRADIOL; 2 METHOXYESTRADIOL BIS SULPHAMATE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; AUTOPHAGY; CARCINOMA CELL; CELL COUNT; CELL DEATH; CELL GROWTH; CELL STRUCTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EXPOSURE; ESOPHAGUS CARCINOMA; IN VITRO STUDY; PILOT STUDY;

APOPTOSIS; AUTOPHAGY; CARCINOMA, SQUAMOUS CELL; CELL COUNT; CELL CYCLE; CELL DIVISION; CELL LINE, TUMOR; DOSE-RESPONSE RELATIONSHIP, DRUG; ESOPHAGEAL NEOPLASMS; ESTRIOL; HUMANS; MICROSCOPY, INTERFERENCE; PILOT PROJECTS; STAINING AND LABELING;

EID: 79952812631     PISSN: 03279545     EISSN: 16675746     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Azad MB, Chen Y, Gibson SB (2009). Regulation of autophagy by reactive oxygen species (ROS): Implications for Cancer Progression and Treatment. Antioxidants & Redox Signaling 11 (4): 777-790.
2. Cushman M, He HM, Katzenellenbogen JA, Lin CM, Hamel E (1995). Synthesis, antitubulin and antimitotic activity, and cytotoxicity of analogs of 2-methoxyestradiol, an endogenous mammalian metabolite of estradiol that inhibits tubulin polymerization by binding to the colchicine binding site. Journal of Medical Chemistry 38: 2041-2049.
3. Davies-Coleman MT, Froneman W, Keyzers RA, Whibley C, Hendricks D, Samaal T, McQuaid C (2005). Anti-oesophageal cancer activity in extracts of deep-water Marion Island sponges. South African Journal of Science 101: 489-490.
4. Day JM, Newman SP, Comninos A, Solomon C, Purohit A, Leese MP, Potter BVL, Reed MJ (2003). The effects of 2-substituted oestrogen sulphamates on the growth of prostate and ovarian cancer cells. Journal of Steroid Biochemistry & Molecular Biology 84: 317-325.
5. Dingli D, Timm M, Russell SJ, Witzig TE, Rajkumar SV (2002). Promising preclinical Activity of 2-Methoxyestradiol in Multiple Myeloma. Clinical Cancer Research 8: 3948-3954.
6. Foster PA, Ho YT, Newman SP, Kasprzyk PG, Leese MP, Potter BVL, Reed MJ, Purohit A (2008). 2-MeOE2bisMATE and 2- EtE2bisMATE induce cell cycle arrest and apoptosis in breast cancer xenografts as shown by a novel ex vivo technique. Breast Cancer Research Treatment 111 (2): 251-260.
7. Fotsis T, Zhang Y, Pepper MS, Adlercreutz H, Montesano R, Nawroth PP, Schweigerer L (1994). The endogenous oestrogen metabolite 2-methoxyoestradiol inhibits angiogenesis and suppresses tumour growth. Nature 368: 237-239.
8. Ireson CR, Chander SK, Purohit A, Perera S, Newman SP, Parish D, Leese MP, Smith AC, Potter BVL, Reed MJ (2004). Pharmacokinetics and efficacy of 2-methoxyoestradiol and 2- methoxyoestradiol-bis-sulphamate in vivo in rodents. British Journal of Cancer 90: 932-937.
9. Lakhani NJ, Sarkar MA, Venitz J, Figg WD (2003). 2-Methoxyestradiol, a promising anticancer agent. Pharmacotherapy 23: 165-172.
10. Lippert C, Seeger H, Mueck AO (2000). The effect of endogenous estradiol metabolites on the proliferation of human breast cancer cells. Life Sciences 72: 877-883.
11. Lottering M-L, Hang M, Seegers JC (1992). Effects of 17-β-estradiol metabolites on cell cycle events in MCF-7 cells. Cancer Research 52: 5926-5932.
12. Newman SP, Ireson CR, Tutill HJ, Day JM, Parsons MFC, Leese MP, Potter BVL, Reed MJ, Purohit A (2006). The role of 17β- bydroxysteroid dehydrogenases in modulating the activity of2-methoxyestradiol in breast cancer cells. Cancer Research 66: 324-330.
13. Newman SP, Foster PA, Stengel C, Day JM, Ho YT, Leese MP, Potter BVL, Reed MJ, Purohit A (2008). STX140 is efficacious in vitro and in vivo in taxane-resistant breast carcinoma cells. Clinical Cancer Research 14: 597-606.
14. Pribluda VS, Gubish ER Jr, LaVallee TM, Treston A, Swartz GM, Green SJ (2000). 2 Methoxyestradiol: an endogenous antiangiogenic and antiproliferative drug candidate. Cancer Metastasis Reviews 19: 173-179.
15. Purohit A, Woo LWL, Chander SK, Newman SP, Ireson C, Ho Y, Grasso A, Leese MP, Potter BVL, Reed MJ (2001). Non-steroidal and steroidal sulfamates: new drugs for cancer therapy. Molecular & Cell Endocrinology 171: 129-135.
16. Purohit A, Woo LWL, Chander SK, Newman SP, Ireson C, Ho Y, Grasso A, Leese MP, Potter BVL, Reed MJ (2003). Steroid sulphatase inhibitors for breast cancer therapy. Journal of Steroid Biochemistry & Molecular Biology 86: 423-432.
17. Raobaikady B, Purohit A, Chander SK, Woo LWL, Leese MP, Potter BVL, Reed MJ (2003). Inhibition of MCF-7 breast cancer cell proliferation and in vivo steroid sulphatase activity by 2- methoxyoestradiol-bis-sulphamate. Journal of Steroid Biochemistry & Molecular Biology 84: 351-358.
18. Sano T, Hirasawa G, Takeyama J, Darnel AD, Suzuki T, Moriya T, Kato K, Sekine H, Ohara S, Shimosegawa T, Nakamura J, Yoshihama M, Harada N, Sasano H (2001). 17 betahydroxysteroid dehydrogenase type 2 expression and enzyme activity in the human gastrointestinal tract. Clinical Science (London) 101: 485-491.
19. Schumacher G, Neuhaus P (2001). The physiological estrogen metabolite 2-methoxyestradiol reduces tumor growth and induces apoptosis in human solid tumors. Journal of Cancer Research and Clinical Oncolology 127: 405-410.
20. Suzuki RN, Newman SP, Purohit A, Leese MP, Potter BVL, Reed MJ (2003). Growth inhibition of multi-drug-resistant breast cancer cells by 2-methoxyoestradiol-bis-sulphamate and 2-ethyloestradiol-bis-sulphamate. Journal of Steroid Biochemistry & Molecular Biology 84: 269-278.
21. Tagg SLC, Foster PA, Leese MP, Potter BVL, Reed MJ, Purohit A, Newman SP (2008). 2-Methoxyoestradiol-3,17-O,O-bissulphamate and 2-deoxy-D-glucose in combination: a potential treatment for breast and prostate cancer. British Journal of Cancer 99: 1842-1848.
22. Thaver V, Lottering M, van Papendorp D, Joubert A (2009). In vitro effects of 2-methoxyestradiol on cell numbers, morphology, cell cycle progression, and apoptosis induction in oesophageal carcinoma cells. Cell Biochemistry Function 24: 205-210.
23. Utsumi T, Leese MP, Chander SK, Gaukroger K, Purohit A, Newman SP, Potter BVL, Reed MJ (2005). The effects of 2-methoxyoestrogen sulphamates on the in vitro and in vivo proliferation of breast cancer cells. Journal of Steroid Biochemistry & Molecular Biology 94: 219-227.
24. Visagie MH, Joubert AM (2008). Influence of 2-methoxyestradiolbis-sulphamate on cell growth, morphology and cell death in MCF-7 and MCF-12A cells. Hons. Poster, Department of Physiology, University of Pretoria, South Africa.
25. Wood L, Leese MP, Mouzakiti A, Purohit A, Potter BVL, Reed MJ, Packham G (2004). 2-MeOE2bisMATE induces caspase-dependent apoptosis in CAL51 breast cancer cells and overcomes resistance to TRAIL via cooperative activation of caspases. Apoptosis 9: 323-332.